Literature DB >> 21228648

Treatment of attention-deficit hyperactivity disorder in athletes.

Jeffrey S Kutcher1.   

Abstract

Attention-deficit hyperactivity disorder (ADHD) is a neurobehavioral development disorder affecting an estimated 6% to 9% of youth in the United States. The typical manifestations of ADHD, attention difficulties and hyperactivity, cause impairment in social and academic functioning, while common comorbid conditions can add significantly to the disease burden. Diagnosing ADHD requires a comprehensive clinical approach. Many medications have been shown to provide benefit for patients with ADHD, and a positive response to medication can be an important factor in clarifying the diagnosis. Medical therapy is of particular interest when treating athletes, as competitive bodies ban many treatment options. This review provides the sports medicine provider with a framework for the treatment of ADHD in the athlete.

Entities:  

Mesh:

Year:  2011        PMID: 21228648     DOI: 10.1249/JSR.0b013e3182091d79

Source DB:  PubMed          Journal:  Curr Sports Med Rep        ISSN: 1537-890X            Impact factor:   1.733


  6 in total

1.  Factors Associated With Musculoskeletal Injuries in Children and Adolescents With Attention-Deficit/Hyperactivity Disorder.

Authors:  Jeffrey A Guy; Lisa M Knight; Yinding Wang; Jeanette M Jerrell
Journal:  Prim Care Companion CNS Disord       Date:  2016-06-23

Review 2.  Considerations in the Use of Stimulants in Sport.

Authors:  Claudia L Reardon; Robert M Factor
Journal:  Sports Med       Date:  2016-05       Impact factor: 11.136

Review 3.  Evidence-Based Considerations and Recommendations for Athletic Trainers Caring for Patients With Attention-Deficit/Hyperactivity Disorder.

Authors:  Elizabeth S Wolfe; Kelly J Madden
Journal:  J Athl Train       Date:  2016-11-11       Impact factor: 2.860

4.  A Controlled Evaluation of a Sport-Specific Performance Optimization Program in an Athlete Diagnosed With Attention Deficit Hyperactivity Disorder and Oppositional Defiant Disorder Within the Context of COVID-19.

Authors:  Davy Phrathep; Brad Donohue; Shane Kraus; Michelle Paul; John Mercer
Journal:  Clin Case Stud       Date:  2022-06

Review 5.  Attention Deficit Hyperactivity Disorder: Unique Considerations in Athletes.

Authors:  Chaney G Stewman; Catherine Liebman; Laura Fink; Brad Sandella
Journal:  Sports Health       Date:  2017-11-16       Impact factor: 3.843

6.  Prescription stimulants in individuals with and without attention deficit hyperactivity disorder: misuse, cognitive impact, and adverse effects.

Authors:  Shaheen E Lakhan; Annette Kirchgessner
Journal:  Brain Behav       Date:  2012-07-23       Impact factor: 2.708

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.